Search research articles
Contact Us
Filters
Showing results (351-360 of 365) with videos related to
Page
of 37
Sort By:
Journal of Medicinal Chemistry
|
April 7, 2026
Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation
Brian T Hopkins, Isaac E Marx, Harlod George Vandeveer, et al.
Journal of Neurotrauma
|
November 3, 2022
White Matter Microstructure Is Associated with Serum Neuroactive Steroids and Psychological Functioning
Lisa F Umminger, Philine Rojczyk, Johanna Seitz-Holland, et al.
Circulation
|
March 18, 2026
Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis
Faizan Khan, Vignan Yogendrakumar, Ronda Lun, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2016
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement
Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
Correction to "Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable <i>in Vivo</i> Target Engagement"
Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
American Journal of Hematology
|
December 19, 2024
Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study
Nilanjan Ghosh, Toby A Eyre, Jennifer R Brown, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
Matthew M Weiss, Thomas A Dineen, Isaac E Marx, et al.
Emerging Infectious Diseases
|
November 26, 2024
Bartonella quintana Infection in Kidney Transplant Recipients from Donor Experiencing Homelessness, United States, 2022
Amy M Beeson, Shannan N Rich, Michael E Russo, et al.
Journal of Medicinal Chemistry
|
May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis
Martin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Clinical Epigenetics
|
March 16, 2020
An epigenome-wide association study of posttraumatic stress disorder in US veterans implicates several new DNA methylation loci
Mark W Logue, Mark W Miller, Erika J Wolf, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 365) with videos related to
Sort By:
Page
of 37
Journal of Medicinal Chemistry
|
April 7, 2026
Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation
Brian T Hopkins, Isaac E Marx, Harlod George Vandeveer, et al.
Journal of Neurotrauma
|
November 3, 2022
White Matter Microstructure Is Associated with Serum Neuroactive Steroids and Psychological Functioning
Lisa F Umminger, Philine Rojczyk, Johanna Seitz-Holland, et al.
Circulation
|
March 18, 2026
Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis
Faizan Khan, Vignan Yogendrakumar, Ronda Lun, et al.
ACS Medicinal Chemistry Letters
|
December 21, 2016
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement
Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
ACS Medicinal Chemistry Letters
|
March 25, 2017
Correction to "Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable <i>in Vivo</i> Target Engagement"
Isaac E Marx, Thomas A Dineen, Jessica Able, et al.
American Journal of Hematology
|
December 19, 2024
Treatment Effectiveness of Venetoclax-Based Therapy After Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: An International Real-World Study
Nilanjan Ghosh, Toby A Eyre, Jennifer R Brown, et al.
Journal of Medicinal Chemistry
|
March 14, 2017
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency and Pharmacokinetics While Mitigating Metabolic Liabilities
Matthew M Weiss, Thomas A Dineen, Isaac E Marx, et al.
Emerging Infectious Diseases
|
November 26, 2024
Bartonella quintana Infection in Kidney Transplant Recipients from Donor Experiencing Homelessness, United States, 2022
Amy M Beeson, Shannan N Rich, Michael E Russo, et al.
Journal of Medicinal Chemistry
|
May 7, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis
Martin K Himmelbauer, Bekim Bajrami, Rebecca Basile, et al.
Clinical Epigenetics
|
March 16, 2020
An epigenome-wide association study of posttraumatic stress disorder in US veterans implicates several new DNA methylation loci
Mark W Logue, Mark W Miller, Erika J Wolf, et al.
Page
of 37